| scholarly article | Q13442814 |
| P50 | author | Jorge Castillo | Q37838479 |
| Brady Beltrán | Q37842527 | ||
| Domingo Morales | Q83158459 | ||
| P2093 | author name string | Eduardo M Sotomayor | |
| Christian Aguilar | |||
| Pilar Quiñones | |||
| Julio C Chavez | |||
| P2860 | cites work | Inflammation and cancer | Q24649640 |
| Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis | Q27022482 | ||
| A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 | ||
| Paradoxical roles of the immune system during cancer development | Q29614305 | ||
| Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma | Q31116522 | ||
| International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes | Q34594231 | ||
| Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy | Q35784338 | ||
| Treatment of T-cell non-Hodgkin's lymphoma. | Q35826477 | ||
| Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients | Q36764002 | ||
| Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas | Q37416054 | ||
| The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Q37507473 | ||
| Cellular and molecular pathways linking inflammation and cancer | Q37555395 | ||
| Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases | Q38053996 | ||
| CD79B limits response of diffuse large B cell lymphoma to ibrutinib | Q38809445 | ||
| Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies | Q40146905 | ||
| Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score | Q40331158 | ||
| Predicting survival for diffuse large B‐cell lymphoma patients using baseline neutrophil/lymphocyte ratio | Q42906974 | ||
| Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy | Q43249152 | ||
| Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. | Q43725941 | ||
| Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era. | Q44404015 | ||
| Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab | Q46437615 | ||
| Prognostic impact of monocyte count at presentation in mantle cell lymphoma. | Q50798505 | ||
| Comparison of four prognostic scores in peripheral T-cell lymphoma. | Q51552972 | ||
| Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. | Q51711182 | ||
| The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. | Q53132335 | ||
| Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification | Q58041476 | ||
| P433 | issue | 1 | |
| P921 | main subject | peripheral T-cell lymphoma | Q7168693 |
| P304 | page(s) | 58-62 | |
| P577 | publication date | 2015-06-19 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified | |
| P478 | volume | 57 |
| Q90812985 | A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study |
| Q48365219 | A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas |
| Q55008919 | Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs. |
| Q92885765 | Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma |
| Q39503272 | Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides |
| Q42320932 | Novel biomarkers for patients with idiopathic acute anterior uveitis: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio |
| Q52577773 | Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network. |
| Q47098146 | Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma |
| Q30239985 | T-cell Lymphoma Epidemiology: the Known and Unknown |
| Q95267907 | The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review |
| Q92541856 | The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma |
Search more.